CRA International appoints Zealey: Barrington rates CRA International stock Buy
Published on 10/07/2026 at 05:22 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
CRA International (ISIN US12618T1051) appointed Christopher Zealey as a vice president in its Life Sciences Practice on October 6, 2026, according to Investor Relations. On October 1, 2026, Barrington analyst Kevin Steinke maintained a Buy rating and set a USD 245.00 price target for CRA International, as reported by Markets Insider.
Life sciences expansion adds capacity
Zealey's appointment expands CRA's commercial strategy expertise in life sciences, a practice tied to regulatory, economic and business consulting. The move follows CRA's September 29, 2026 appointment of Patrick Hillan as a vice president, according to the company's investor-relations page.
Second-quarter growth supports guidance
CRA reported fiscal second-quarter 2026 revenue of USD 210.80 million, up 12.80 percent from USD 186.88 million a year earlier, according to its second-quarter results release. Net income increased 11.40 percent to USD 13.50 million, while GAAP earnings per diluted share rose 17.30 percent to USD 2.10 from USD 1.79.
The company raised its fiscal 2026 constant-currency revenue guidance to USD 805 million-USD 820 million from USD 785 million-USD 805 million. It also reaffirmed its non-GAAP EBITDA margin guidance at 12.00 percent-13.00 percent, giving the analyst target a fundamental backdrop beyond the latest management appointment.
Stock valuation meets a wide range
CRAI had a market capitalization of USD 1.1 billion and a 52-week range of USD 132.17 to USD 227.29 as of October 6, 2026. The upper end of that range is USD 56.00 above the USD 171.29 primary-market reference used in the latest finance quote, while the company reported USD 21.44 million in cash at the end of the fiscal second quarter.
CRA's results release also points to demand timing, competition, foreign-exchange changes and global economic conditions as factors that can affect fiscal 2026 results. For investors, the key tension is clear: the company is expanding its advisory platform while guiding to double-digit revenue growth for the year.
CRA International stock facts
- Company: CRA International, Inc.
- ISIN: US12618T1051
- Ticker: CRAI
- Primary exchange: NASDAQ
- Market capitalization: USD 1.1 billion as of October 6, 2026
- 52-week range: USD 132.17-227.29 as of October 6, 2026
More news and analyses on CRA International stock.
